New Appointments

New Appointments

November 02, 2015

Trajan Scientific and Medical has significantly bolstered its global team, announcing four new appointments that add enviable skills and extensive experience to the organization as it continues to grow and expand around the world.

The appointments point to a strategic migration of the global footprint for Trajan, expanding in key markets such as Asia with the appointment of Takeyoshi Ide as Sales Manager Japan. Mr Ide brings significant expertise not only in chromatography, but also the life science market.

Bridging the gap between the academic world and real life is a major focus for Trajan, as demonstrated by the appointment of Dr Robert (Rob) Shellie as Chromatography Market Manager. Dr Shellie was Associate Professor of Chemistry at the University of Tasmania in Hobart, Australia prior to joining Trajan. With multiple achievements of international recognition Dr Shellie is well experienced at translating chromatography technologies into meaningful applications.

Trajan’s focus is on developing and commercialising technologies that enable analytical systems to be more selective, sensitive and specific for biological, environmental or food related measurements - especially those that can lead to portability, miniaturization and affordability.

The appointment of Dr Pawanbir Singh as Pathology Market Manager from medical device and life science organizations including Leica Biosystems and STEMCELL Technologies, is a tangible demonstration of the strategic importance placed on this focus. Dr Singh pursued a PhD at the Centre for Biological Engineering at Loughborough University where he worked on scale-up and process optimization of regenerative medicine based products, developing an industry investment readiness reference model for these products as part of his doctoral studies.

In other new appointment news, Dr Michelle Carr joins as Commercialization Manager based in Melbourne, Australia. Dr Carr was CEO of Telezon Limited, a technology company focussed on unique processes for polymer injection systems.

Chief Executive Officer of Trajan, Stephen Tomisich comments: "Trajan is proud to be expanding its global team with people who bring complementary experience to the table. We are serious about continuing the growth of our team around the world, all united in fulfilling our passion to develop technologies that will impact human wellbeing."




Also in News

Trajan Scientific and Medical continues its focus on Microsampling
Trajan Scientific and Medical continues its focus on Microsampling

April 20, 2022

Trajan Scientific and Medical, (Trajan, ASX:TRJ) partnered with researchers at The University of Queensland to develop a skin microbiopsy device which takes tissue samples smaller than 0.5mm in diameter.  It can be used to collect biopsies for skin conditions, including skin cancers.

Read More

Cathy Cordova Appointed Trajan's General Manager of Microsampling Unit
Cathy Cordova Appointed Trajan's General Manager of Microsampling Unit

February 16, 2022

Cathy Cordova has been appointed the General Manager of the consolidated Microsampling Business Unit for Trajan Scientific and Medical.

Read More

Dr Xumei Gao (Bryan) awarded REDI fellowship to partner with Trajan.
Dr Xumei Gao (Bryan) awarded REDI fellowship to partner with Trajan.

January 27, 2022

 Dr Xumei Gao (Bryan) a Postdoctoral Researcher from the ARC Training Centre for Personalized Therapeutics Technologies at the University of Melbourne, has been awarded a REDI fellowship to partner with Trajan.

Read More